BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the target of a large decrease in short interest during the month of July. As of July 15th, there was short interest totaling 3,503 shares, a decrease of 76.1% from the June 30th total of 14,642 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily volume of 5,583 shares, the short-interest ratio is presently 0.6 days.
BioNexus Gene Lab Price Performance
BGLC stock opened at $1.37 on Tuesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.53 and a quick ratio of 5.69. BioNexus Gene Lab has a 1 year low of $1.07 and a 1 year high of $8.98. The company’s 50-day moving average is $2.05 and its 200-day moving average is $2.33. The stock has a market capitalization of $3.31 million, a PE ratio of -0.93 and a beta of 4.08.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.23) earnings per share for the quarter. The firm had revenue of $0.02 million for the quarter. BioNexus Gene Lab had a negative return on equity of 37.43% and a negative net margin of 54.70%.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on BGLC
Institutional Trading of BioNexus Gene Lab
A hedge fund recently raised its stake in BioNexus Gene Lab stock. DRW Securities LLC grew its position in shares of BioNexus Gene Lab Corp. (NASDAQ:BGLC – Free Report) by 226.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,830 shares of the company’s stock after buying an additional 33,179 shares during the quarter. DRW Securities LLC owned 2.02% of BioNexus Gene Lab worth $189,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 18.85% of the company’s stock.
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Featured Stories
- Five stocks we like better than BioNexus Gene Lab
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.
